Skip to main content

Classification of Microorganisms According to Their Pathogenicity

  • Chapter
  • First Online:
Infection Control in the Intensive Care Unit

Abstract

Microorganisms are classified into three major groups: low-level pathogens, high-level pathogens, and potential pathogens. They are classified using the intrinsic pathogenicity index (IPI), defined as the ratio between the number of patients infected by a particular microorganism and the number of patients who carry the identical microorganism in the throat and/or gut. Indigenous anaerobes rarely cause infections, despite being carried in high concentrations by everyone, and have an IPI between 0.01 and 0.03. Enterococci and coagulase-negative staphylococci are also carried in the oropharynx in high concentrations by a substantial percentage of patients requiring treatment in the intensive care unit but are unable to cause lower airway infections. These are low-level pathogens, whereas high-level pathogens such as Salmonellae have an IPI approaching 1. There are about 15 potential pathogens with IPIs between 0.1 and 0.3. These include six normal potential pathogens carried by healthy individuals and nine abnormal potential pathogens carried by patients with an acute or chronic condition. Evidence supports the concept that antibiotic resistance does not contribute to mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Isenberg HD (1988) Pathogenicity and virulence: another view. Clin Microbiol Rev 1:40–53

    PubMed  CAS  Google Scholar 

  2. Brachman PS (1992) Epidemiology of nosocomial infections. In: Bennett JV, Brachman PS (eds) Hospital infections, 3rd edn. Little Brown, Boston, pp 3–20

    Google Scholar 

  3. Murray AE, Mostafa SM, van Saene HKF (1991) Essentials in clinical microbiology. In: Stoutenbeek CP, van Saene HKF (eds) Infection and the anaesthetist, vol 5. Bailliere Tindall, London, pp 1–26

    Google Scholar 

  4. McCloskey RV (1979) Microbial virulence factors. In: Mandell GL, Douglas RG, Bennett IE (eds) Principles and practice of infectious diseases, vol 1, 1st edn. Wiley, New York, pp 3–11

    Google Scholar 

  5. Pfaller MA, Herwald LA (1988) Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1:281–299

    PubMed  CAS  Google Scholar 

  6. Freeman I, Platt R, Sidebottom DG et al (1987) Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. JAMA 258:2548–2552

    Article  PubMed  CAS  Google Scholar 

  7. Kerver AIH, Rommes IH, Mevissen-Verhage EAE et al (1987) Colonization and infection in surgical intensive care patients. Intensive Care Med 13:347–351

    Article  PubMed  CAS  Google Scholar 

  8. Leonard EM, van Saene HKF, Shears P, Walker I, Tam PKH (1990) Pathogenesis of colonization and infection in a neonatal surgical unit. Crit Care Med 18:264–269

    Article  PubMed  CAS  Google Scholar 

  9. van Saene HKF, Stoutenbeek CP, Zandstra DF, Gilberston A, Murray A, Hart CA (1987) Nosocomial infections in severely traumatized patient: magnitude of problem, pathogenesis, prevention and therapy. Acta Anaesthesiol Belg 38:347–356

    PubMed  Google Scholar 

  10. van Saene HKF, Damjanovic V, Murray AE, de la Cal MA (1996) How to classify infections in intensive care units—the carrier state, a criterion whose time has come? J Hosp Infect 33:1–12

    Article  PubMed  Google Scholar 

  11. Tramont EC (1979) General or nonspecific host defense mechanisms. In: Mandell GL, Douglas RG, Bennett IE (eds) Principles and practice of infectious diseases, vol 1, 1st edn. Wiley, NewYork, pp 13–21

    Google Scholar 

  12. Isenberg HD, D’Amato RF (1990) Indigenous and pathogenic micro-organisms of humans. In: Mandell GL, Douglas RG, Bennett IE (eds) Principles and practice of infectious diseases, vol 1, 3rd edn. Churchill Livingstone, New York, pp 2–14

    Google Scholar 

  13. Jordan GW, Wong GA, Hoeprich PB (1976) Bacteriology of the lower respiratory tract as determined by fiberoptic bronchoscopy and transtracheal aspiration. J Infect Dis 134:428–435

    Article  PubMed  CAS  Google Scholar 

  14. van der Waaij D (1992) Selective gastrointestinal decontamination: history of recognition and measurement of colonization of the digestive tract as an introduction to selective gastrointestinal decontamination. Epidemiol Infect 109:315–326

    Article  PubMed  Google Scholar 

  15. Mackowiak PA, Martin RM, Smith LW (1979) The role of bacterial interference in the increased prevalence of oropharyngeal Gram-negative bacilli among alcoholics and diabetics. Am Rev Respir Dis 120:289–593

    Google Scholar 

  16. Leonard EM, van Saene HKF, Stoutenbeek CP, Walker I, Tam PKH (1990) An intrinsic pathogenicity index for micro-organisms causing infection in a neonatal surgical unit. Microb Ecol Health Dis 3:151–157

    Article  Google Scholar 

  17. Shelhamer IH, Toews GB, Masur H et al (1992) Respiratory disease in the immuno-suppressed patient. Ann Intern Med 117:415–443

    PubMed  CAS  Google Scholar 

  18. Alvarez-Lerma F (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-acquired pneumonia study group. Intensive Care Med 22:387–394

    Article  PubMed  CAS  Google Scholar 

  19. Luna CM, Vujacich P, Niederman MS et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685

    Article  PubMed  CAS  Google Scholar 

  20. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator associated pneumonia. Chest 122:262–268

    Article  PubMed  Google Scholar 

  21. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA (2003) Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123:1615–1624

    Article  PubMed  Google Scholar 

  22. Fagon JY, Chastre J, Wolff M et al (2000) Invasive and noninvasive strategies for management of suspected ventilator associated pneumonia. A randomized trial. Ann Intern Med 132:621–630

    PubMed  CAS  Google Scholar 

  23. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59

    Article  PubMed  Google Scholar 

  24. Conterno LO, Wey SB, Castelo A (1998) Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19:32–37

    Article  PubMed  CAS  Google Scholar 

  25. Romero-Vivas J, Rubio M, Fernández C, Picazo JJ (1995) Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21:1417–1423

    Article  PubMed  CAS  Google Scholar 

  26. Harbarth S, Rutschmann O, Sudre P, Pittet D (1998) Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158:182–189

    Article  PubMed  CAS  Google Scholar 

  27. Soriano A, Martínez JA, Mensa J et al (2000) Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30:368–373

    Article  PubMed  CAS  Google Scholar 

  28. Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31:1170–1174

    Article  PubMed  CAS  Google Scholar 

  29. Topeli A, Unal S, Akalin HE (2000) Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital. Int J Antimicrob Agents 141:57–63

    Article  Google Scholar 

  30. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29:1171–1177

    Article  PubMed  Google Scholar 

  31. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM (2000) Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 30:466–472

    Article  PubMed  CAS  Google Scholar 

  32. Vergis EN, Hayden MK, Chow JW et al (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 135:484–492

    PubMed  CAS  Google Scholar 

  33. Lodise TP, McKinnon PS, Tam VH, Rybak MJ (2002) Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 34:922–929

    Article  PubMed  Google Scholar 

  34. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34:1047–1054

    Article  PubMed  CAS  Google Scholar 

  35. Alverdy JC, Laughlin RS, Wu L (2003) Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit Care Med 31:598–607

    Article  PubMed  Google Scholar 

  36. Relman DA, Falkow S (1990) A molecular perspective of microbial pathogenicicty. In: Mandell GL, Douglas RG, Bennett IE (eds) Principles and practice of infectious diseases, vol 1, 3rd edn. Churchill Livingstone, New York, pp 25–32

    Google Scholar 

  37. Emori TG, Gaynes RG (1993) An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 6:428–442

    PubMed  CAS  Google Scholar 

  38. Neish AS (2002) The gut microflora and intestinal epithelial cells: a continuing dialogue. Microbes Infect 4:309–317

    Article  PubMed  Google Scholar 

  39. Guarner F, Malagelada JR (2003) Gutflora in health and disease. Lancet 361:512–519

    Article  PubMed  Google Scholar 

  40. D’Agata EMC, Venkataran L, De Girolami P, Burke P, Eliopoulos GM, Karchmer AW, Samore MH (1999) Colonisation with broad-spectrum cephalosporin-resistant Gram-negative bacilli in intensive care units during a non-outbreak period: prevalence, risk factors and rate of infection. Crit Care Med 27:1090–1095

    Article  PubMed  Google Scholar 

  41. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus Gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med 136:834–844

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. A. de la Cal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

de la Cal, M.A., Cerdà, E., Abella, A., Garcia-Hierro, P. (2011). Classification of Microorganisms According to Their Pathogenicity. In: van Saene, H., Silvestri, L., de la Cal, M., Gullo, A. (eds) Infection Control in the Intensive Care Unit. Springer, Milano. https://doi.org/10.1007/978-88-470-1601-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1601-9_3

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1600-2

  • Online ISBN: 978-88-470-1601-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics